Siegfried Köhler

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +4

Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system

Tobias Alexander, Andreas Thiel, Oliver Rosen et al. · Blood · 2008 · 310 citations · Full text

Life Sciences, Hematology, Immunology +17

Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)

Julie Bernhardt, Leonid Churilov, Fiona Ellery et al. · Neurology · 2016 · 217 citations · Full text

Medicine, Rehabilitation Medicine, Geriatric Rehabilitation +14

Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis

Franziska Scheibe, Annerose Mengel, Siegfried Köhler et al. · Neurology · 2016 · 202 citations

Medicine, Neurology, Pharmacology +15

Myasthenic crisis demanding mechanical ventilation

Bernhard Neumann, Klemens Angstwurm, Philipp Mergenthaler et al. · Neurology · 2019 · 162 citations

Health Professions, Respiratory Therapy, Crisis Intervention +7